Press releases
- Press releases
- Browse
Press releases
Merz Pharma KGaA, specializing in the treatment of diseases of the central nervous system and of esthetic dermatology, has received approval for the first-ever pure botulinum toxin type A (BoNT/A). More
Endo announced today that it has entered into an agreement with ProEthic to commercialize the Ketoprofen Patch developed by APR More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
The world's only medication approved for the treatment of moderate to severe Alzheimer's dementia on its way to success. More
Astex Technology, announced that it has received the second milestone payment from AstraZeneca as part of its collaboration to identify novel drugs against a key protein target implicated in Alzheimer's Disease. More
AMARIN REPORTS INITIATION OF ENROLLMENT AND FIRST PATIENT DOSING IN PIVOTAL PHASE III CLINICAL TRIALS FOR MIRAXION IN HUNTINGTON'S DISEASE More
Amarin announces results from pre-clinical research conducted at Trinity College, Dublin More
Consistent data in three Phase IIa clinical trials in depression patients with melancholic characteristics More
Lay Line Genomics licenses AD11 mouse model for Alzheimer's disease to Johnson & Johnson Pharmaceutical Research & Development. More
The safety data from Active Biotech's (Stockholm: ACTI.ST) recently concluded clinical phase II safety study shows that laquinimod, a novel oral medication for the treatment of multiple sclerosis (MS), was well tolerated also at a higher dose. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 1068 pages - $2,495
Oct 2010 - 53 pages - $1,000
Sep 2011 - 97 pages - $3,500
Feb 2011 - 75 pages - $1,000
Jan 2010 - $75
Apr 2006 - 310 pages - $3,500
Apr 2008 - 250 pages - $3,995
Nov 2011 - 61 pages - $3,800
Mar 2011 - 17 pages - $250
Jan 2010 - $75
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Age-related disorders (other)
- Amyotrophic lateral sclerosis
- CNS (other)
- Neurodegenerative disorders
- Neurological
- Pain
- Psychiatric
- Subarachnoid hemorrhage
- Traumatic brain injury
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us